Zusammenfassung
Hintergrund
Die Schizophrenie ist ein komplexes psychiatrisches Störungsbild, dessen Primärbehandlung aktuell mit Antipsychotika erfolgt.
Ziel der Arbeit
Das Metakognitive Training (MKT), das als Gruppen- und Einzeltraining zur Verfügung steht, hat zum Ziel, den Patienten in spielerischer Atmosphäre für kognitive Verzerrungen, z. B. voreiliges Schlussfolgern oder Unkorrigierbarkeit, denen ein Einfluss bei der Entstehung und Aufrechterhaltung der Schizophrenie zugesprochen wird, zu sensibilisieren.
Material und Methode
In diesem Beitrag wird ein Überblick über den Hintergrund und die Inhalte des MKT bei Schizophrenie sowie über die aktuelle Forschungslage zum MKT gegeben.
Ergebnisse
Die Mehrzahl der bislang durchgeführten Studien bestätigt die Effektivität des MKT in Bezug auf Positivsymptomatik und kognitive Verzerrungen. Weitere Forschung ist nötig, um die langfristige Effektivität des MKT zu bestätigen und genauere Kenntnisse über die genauen Wirkmechanismen des MKT zu erhalten.
Schlussfolgerungen
Das MKT kann als vielversprechende Komplementärmaßnahme zur pharmakologischen Therapie angesehen werden.
Abstract
Background
Schizophrenia is a complex psychiatric disorder for which antipsychotic medications are still the cornerstone of treatment.
Aim
Metacognitive training (MCT) represents a novel psychological intervention, which focuses on cognitive biases, such as jumping to conclusions and incorrigibility, which have been shown to contribute to the formation and maintenance of delusional thoughts.
Material and methods
In this review the theoretical foundations of MCT are discussed and currently available findings on the feasibility, acceptability and efficacy are presented.
Results
Most, but not all, studies have demonstrated that MCT has a moderate effect in reducing both positive symptoms and cognitive biases. Further work is needed to confirm the long-term efficacy and mechanism of action.
Conclusion
Given these findings, MCT appears to hold special promise as a complementary approach.
Literatur
Aghotor J, Pfueller U, Moritz S, Weisbrod M, Roesch-Ely D (2010) Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacy. J Behav Ther Exp Psychiatry 41(3):207–211. doi:10.1016/j.jbtep.2010.01.004
Andreou C, Moritz S, Veith K, Veckenstedt R, Naber D (2013) Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: a double-blind study. Schizophr Bull 40(3):558–565. doi:10.1093/schbul/sbt064
Balzan RP, Delfabbro PH, Galletly CA, Woodward TS (im Druck) Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single-module programme. Aust N Z J Psychiatry. doi:10.1177/0004867413508451
Barkhof E, Meijer CJ, de Sonneville LMJ, Linszen DH, de Haan L (2012) Interventions to improve adherence to antipsychotic medication in patients with schizophrenia-a review of the past decade. Eur Psychiatry 27(1):9–18. doi:10.1016/j.eurpsy.2011.02.005
Beck AT, Rector NA (2005) Cognitive approaches to schizophrenia: theory and therapy. Annu Rev Clin Psychol 1:577–606. doi:10.1146/annurev.clinpsy.1.102803.144205
Bell V, Halligan PW, Ellis HD (2006) Explaining delusions: a cognitive perspective. Trends Cogn Sci 10(5):219–226. doi:10.1016/j.tics.2006.03.004
Briki M, Monnin J, Haffen E, Sechter D, Favrod J, Netillard C, Cheraitia E, Marin K, Govyadovskaya S, Tio G, Bonin B, Chauvet-Gelinier JC, Leclerc S, Hodé Y, Vidailhet P, Berna F, Bertschy AZ, Vandel P (2014) Metacognitive training for schizophrenia: a multicentre randomised controlled trial. Schizophr Res 157(1–3):99–106. doi:10.1016/j.schres.2014.06.005
Brüne M (2005) „Theory of mind“ in schizophrenia: a review of the literature. Schizophr Bull 31(1):21–42. doi:10.1093/schbul/sbi002
Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale
Combs DR, Adams SD, Penn DL, Roberts D, Tiegreen J, Stem P (2007) Social Cognition and Interaction Training (SCIT) for inpatients with schizophrenia spectrum disorders: preliminary findings. Schizophr Res 91(1–3):112–116. doi:10.1016/j.schres.2006.12.010
Erawati E, Keliat BA, Helena N, Hamid A (2014) The influence of metacognitive training on delusion severity and metacognitive ability in schizophrenia. J Psychiatr Ment Health Nurs 21(9):841–847. doi:10.1111/jpm.12130
Favrod J, Maire A, Bardy S, Pernier S, Bonsack C (2011) Improvng insight into delusions: a pilot study of metacognitive training for patients with schizophrenia. J Adv Nurs 67(2):401–407. doi:10.1111/j.1365-2648.2010.05470.x
Favrod J, Rexhaj S, Bardy S, Ferrari P, Hayoz C, Moritz S, Conus P, Bonsack C (2014) Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study. Eur Psychiatry. doi:10.1016/j.eurpsy.2013.08.003
Freeman D, Garety PA, Kuipers E, Fowler D, Bebbington PE, Dunn G (2007) Acting on persecutory delusions: the importance of safety seeking. Behav Res Ther 45(1):89–99. doi:10.1016/j.brat.2006.01.014
Freeman D, Garety P, Fowler D, Kuipers E, Dunn G, Bebbington P, Hadley C (1998) The London-East Anglia randomized controlled trial of cognitive-behaviour therapy for psychosis. IV: self-esteem and persecutory delusions. Br J Clin Psychol 37(Pt 4):415–430. http://www.ncbi.nlm.nih.gov/pubmed/9856295
Fromm-Reichmann F (1959) Psychoanalysis and psychotherapy. Selected papers (Psychoanalyse und Psychotherapie. Eine Auswahl aus ihren Schriften). University of Chicago Press, Chicago
Garety PA, Freeman D (2013) The past and future of delusions research: from the inexplicable to the treatable. Br J Psychiatry 203(5):327–333. doi:10.1192/bjp.bp.113.126953
Gaweda L, Krezolek M, Olbrys J, Turska A, Kokoszka A (eingereicht) What the meta-cognitive group training is working on among chronic schizophrenia patients? The influence on psychotic symptoms, cognitive biases, insight and general functioning
Haddock G, McCarron J, Tarrier N, Faragher EB (1999) Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med 29(4):879–889. http://www.ncbi.nlm.nih.gov/pubmed/10473315
Hamm JA, Hasson-Ohayon I, Kukla M, Lysaker PH (2013) Individual psychotherapy for schizophrenia: trends and developments in the wake of the recovery movement. Psychol Res Behav Manag 6:45–54. doi:10.2147/PRBM.S47891
Hartmann H (1964) Essays on ego-psychology. Selected problems in psychoanalytic theory. Ich-Psychologie. Studien zur psychoanalytischen Theory. International Universities, New York
Huq SF, Garety PA, Hemsley DR (1988) Probabilistic judgements in deluded and non-deluded subjects. Q J Exp Psychol A 40(4):801–812. doi:10.1080/14640748808402300
Jääskeläinen E, Jula PJ, Hirvonen N, McGrath JJ, Sha S, Isohanni M, Veijola J, Miettunen J (2013) A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull 39(6):1296-1306. doi:10.1093/schbul/sbs130
Kay SR, Fiszbein A, Opler L (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276
Kinnear PR, Gray CD (2008) SPSS16 made simple. Psychology, Hove
Kumar D, Zia Ul Haq M, Dubey I, Dotivala KN, Veqar Siddiqui S, Prakash R, Abhishek P, Nizamie SH (2010) Effect of meta-cognitive training in the reduction of positive symptoms in schizophrenia. Eur J Psychother Counsell Health 12(2):149–158. doi:10.1080/13642537.2010.488875
Lambert M, Conus P, Cotton S, Robinson J, McGorry PD, Schimmelmann BG (2010) Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis. J Clin Psychopharmacol 30(5):565–572. doi:10.1097/JCP.0b013e3181f058a0
Langdon R, Ward PB, Coltheart M (2010) Reasoning anomalies associated with delusions in schizophrenia. Schizophr Bull 36(2):321–330. doi:10.1093/schbul/sbn069
Lempa G, Montag C, von Haebler D (2013) Auf dem Weg zu einem Manual der psychodynamischen Psychosentherapie. Psychotherapeut 58(4):327–338. doi:10.1007/s00278-013-0998-0
Leucht S, Arbter D, Engel RR, Kissling W, Davis JM (2009) How effective are second-generation antipsychotoc drugs? A meta-analysis of placebo-controlled trials. Mol Psychiatr 14(4):429–447. doi:10.1038/sj.mp.4002136
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209–1223. doi:10.1056/NEJMoa051688
Lincoln TM, Ziegler M, Mehl S, Rief W (2010) The jumping to conclusions bias in delusions: specificity and changeability. J Abnorm Psychol 119(1):40–49. doi:10.1037/a0018118
Lüllmann E, Lincoln TM (2013) The effect of an educating versus normalizing approach on treatment motivation in patients presenting with delusions: an experimental investigation with analogue patients. Schizophr Res Treatment 2013:261587. doi:10.1155/2013/261587
Mizrahi R, Kiang M, Mamo DC, Arenovich T, Bagby RM, Zipursky RB, Kapur S (2006) The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disorders. Schizophr Res 88(1–3):111–118. doi:10.1016/j.schres.2006.07.013
Moritz S, Hauschildt M (2012) Erfolgreich gegen Zwangsstörungen: Metakognitives Training – Denkfallen erkennen und entschärfen. Springer-Verlag, Berlin
Moritz S, Woodward TS (2006) A generalized bias against disconfirmatory evidence in schizophrenia. Psychiatry Res 142(2–3):157–165. doi:10.1016/j.psychres.2005.08.016
Moritz S, Woodward TS (2007) Metacognitive training for schizophrenia patients (MCT): a pilot study on feasibility, treatment adherence, and subjective efficacy. German J Psychiatry 10(3):69–78
Moritz S, Woodward TS, Ruff CC (2003) Source monitoring and memory confidence in schizophrenia. Psychol Med 33(1):131–139. http://www.ncbi.nlm.nih.gov/pubmed/12537044
Moritz S, Ferahli S, Naber D (2004) Memory and attention performance in psychiatric patients Lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results. J Int Neuropsychol Soc 10:623–633. doi:10.1017/S135561704104153
Moritz S, Woodward TS, Rodriguez-Raecke R (2006) Patients with schizophrenia do not produce more false memories than controls but are more confident in them. Psychol Med 36(5):659–667. doi:10.1017/S0033291706007252
Moritz S, Woodward TS, Jelinek L, Klinge R (2008) Memory and metamemory in schizophrenia: a liberal acceptance account of psychosis. Psychol Med 38(6):825–832. doi:10.1017/S0033291707002553
Moritz S, Peters, M. J. V, Karow A, Deljkovic A, Tonn P, Naber D (2009) Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients. Ment Illn 1(1):e2. doi:10.4081/mi.2009.e2
Moritz S, Kerstan A, Veckenstedt R, Randjbar S, Vitzthum F, Schmidt C, Heise M, Woodward TS (2011a) Further evidence for the efficacy of a metacognitive group training in schizophrenia. Behav Res Ther 49(3):151–157. doi:10.1016/j.brat.2010.11.010
Moritz S, Veckenstedt R, Randjbar S, Vitzthum F (2011b) MKT+: individualisiertes metakognitives Therapieprogramm für Menschen mit Psychose. [u. a.]. Springer, Berlin
Moritz S, Veckenstedt R, Randjbar S, Vitzthum F, Woodward TS (2011c) Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms. Psychol Med 41(9):1823–1832. doi:10.1017/S0033291710002618
Moritz S, Vitzthum F, Randjbar S, Veckenstedt R, Woodward TS, Metacognition Study Group (2013a) Metakognitives Training für schizophrene Patienten (MKT), 5. Aufl. VanHam Campus Verlag, Hamburg
Moritz S, Andreou C, Klingberg S, Thoering T, Peters MJV (2013b) Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect? Neuropharmacology 72:179–186. doi:10.1016/j.neuropharm.2013.04.039
Moritz S, Veckenstedt R, Bohn F, Hottenrott B, Scheu F, Randjbar S, Aghotor J, Köther U, Woodward TS, Treszl A, Andreou C, Pfueller U, Roesch-Ely D (2013c) Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia. Schizophr Res 151(1–3):61–69. doi:10.1016/j.schres.2013.10.007
Moritz S, Veckenstedt R, Andreou C, Bohn F, Hottenrott B, Leighton L, Scheu F, Roesch-Ely D (2014) Sustained and „sleeper“ effects of groupmetacognitive training in schizophrenia: A randomized clinical trial. JAMA 71(10):1103–1111. doi: 10.1001/jamapsychiatry.2014.1038
Pharoah F, Mari JJ, Rathbone J, Wong W (2010) Family intervention for schizophrenia. Cochrane Database Syst Rev 12. doi: 10.1002/14651858.CD000088.pub2
Randjbar S, Veckenstedt R, Vitzthum F, Hottenrott B, Moritz S (2011) Attributional biases in paranoid schizophrenia: further evidence for a decreased sense of self-causation in paranoia. Psychosis 3:74–85
Rector NA, Beck AT, Stolar N (2005) The negative symptoms of schizophrenia: a cognitive perspective. Can J Psychiatry 50(5):247–257. https://ww1.cpa-apc.org/Publications/Archives/CJP/2005/april/cjp-april-05-Rector-IR.pdf
Rocha NBF, Queirós C (2013) Metacognitive and social cognition training (MSCT) in schizophrenia: a preliminary efficacy study. Schizophr Res 150(1):64–68. doi:10.1016/j.schres.2013.07.057
Rosenheck R, Stroup S, Keefe RSE, McEvoy J, Swartz M, Perkins D, Hsiao J, Shumway M, Lieberman J (2005) Measuring outcome priorities and preferences in people with schizophrenia. Br J Psychiatry 187:529–536. doi:10.1192/bjp.187.6.529
Ross K, Freeman D, Dunn G, Garety P (2011) A randomized experimental investigation of reasoning training for people with delusions. Schizophr Bull 37(2):324–333. doi:10.1093/schbul/sbn165
Savla GN, Vella L, Armstrong CC, Penn DL, Twamley EW (2013) Deficits in domains of social cognition in schizophrenia: a meta-analysis of the empirical evidence. Schizophr Bull 39(5):979–992. doi:10.1093/schbul/sbs080
Schwarz F (2012) Psychodynamik und Psychotherapie psychotischer Störungen. Psychotherapeut 57(6):479–489. doi:10.1007/s00278-012-0946-4
Van der Gaag M (2006) A neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations. Schizophr Bull 32(1):S113–S122. doi:10.1093/schbul/sbl027
Van Oosterhout B, Krabbendam L, de Boer K, Ferwerda J, van der Helm M, Stant AD, van der Gaag M (2014) Metacognitive group training for schizophrenia spectrum patients with delusions: a randomized controlled trial. Psychol Med 44(14):3025–3035. doi:10.1017/S0033291714000555
Waller H, Freeman D, Jolley S, Dunn G, Garety P (2011) Targeting reasoning biases in delusions: a pilot study of the Maudsley review training programme for individuals with persistent, high conviction delusions. J Behav Ther Exp Psychiatry 42(3):414–421. doi:10.1016/j.jbtep.2011.03.001
Woodward TS, Buchy L, Moritz S, Liotti M (2007) A bias against disconfirmatory evidence is associated with delusion proneness in a nonclinical sample. Schizophr Bull 33(4):1023–1028. doi:10.1093/schbul/sbm013
Wykes T, Steel C, Everitt B, Tarrier N (2008) Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 34(3):523–537. doi:10.1093/schbul/sbm114
Zimmermann G, Favrod J, Trieu VH, Pomini V (2005) The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophr Res 77(1):1–9. doi:10.1016/j.schres.2005.02.018
Danksagung
Die Autorinnen möchten sich bei Prof. Steffen Moritz für die Durchsicht einer früheren Manuskriptversion sowie bei Lara Bücker für hilfreiche Kommentare bedanken.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
Martina Fieker und Brooke C. Schneider geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Additional information
Redaktion
Harald Freyberger, Stralsund/GreifswaldBernhard Strauß, JenaAnja Hilbert, Leipzig
Rights and permissions
About this article
Cite this article
Fieker, M., Schneider, B. Metakognitives Training bei Schizophrenie. Psychotherapeut 60, 216–224 (2015). https://doi.org/10.1007/s00278-015-0003-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00278-015-0003-1